InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Browse the detailed record of transactions filed by Lux Venture Partners V, LLC. Officer active across 1 company, notably Eikon Therapeutics, Inc.. Cumulatively, 1 filings have been published. Split: 1 buy · 0 sell. Total volume traded: €2.1m. Activity tracked since 4 February 2026. The latest transaction was disclosed on 4 February 2026 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
1 of 1 declaration